Clinical Trial Update: Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hepatic arterial infusion with floxuridine and dexamethasone, with or without bevacizumab, for hepatic metastases from colorectal cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Decadron (Dexamethasone)
• FUDR (floxuridine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Hepatic Metastases, Colon Cancer | Phase 2 | Status: COMPLETED